Apogee Therapeutics Inc (APGE) PT Raised to $135 at Truist Securities
Tweet
Share
E-mailGet Alerts APGE Hot Sheet
Price: $135.08 --0%
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Truist Securities analyst Danielle Brill raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $135.00 (from $81.00) while maintaining a Hold rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- MiniMed Group (MMED) PT Raised to $28 at BTIG
- Petroleo Brasileiro SA (PETR4:BZ) (PBR) PT Raised to R$58.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
